September 2024 in “Clinical and Experimental Dermatology” COVID-19 increased hair loss cases, but vaccination did not.
September 2024 in “Journal of the American Academy of Dermatology” Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.
September 2024 in “Journal of the American Academy of Dermatology” Telogen effluvium in kids is often caused by illness or poor nutrition, especially in girls.
August 2024 in “International Journal of Health Science” Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.
August 2024 in “Archives of Dermatological Research” Low-dose oral minoxidil is effective and safe for treating androgenetic alopecia.
August 2024 in “Journal of Cosmetic Dermatology” Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.
July 2024 in “Dermatology Practical & Conceptual” COVID-19-related hair loss may have unique features compared to hair loss from other causes.
July 2024 in “Brazilian Journal of Clinical Medicine and Review” Hair loss after bariatric surgery is common due to nutrient deficiencies and rapid weight loss.
July 2024 in “Medical alphabet” Modern therapies, like fractional laser, effectively treat telogen effluvium.
July 2024 in “Influenza and Other Respiratory Viruses” Analyzing both TE and AA together is crucial for understanding post-COVID-19 hair loss.
June 2024 in “Archives of dermatological research” Targeted testing for telogen effluvium patients can save healthcare costs.
Erythropoietin overexpression disrupts hair growth and fat formation in mice.
June 2024 in “Al- Anbar Medical Journal” Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.
June 2024 in “Archives of dermatological research” Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.
Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.
April 2024 in “Dermatovenerologiâ, kosmetologiâ” Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.
April 2024 in “Benha Medical Journal” H. pylori infection may be linked to the hair shedding condition Telogen Effluvium.
April 2024 in “BENTHAM SCIENCE PUBLISHERS eBooks” The document's conclusion cannot be provided because the document is not readable or understandable.
March 2024 in “International journal of research in medical sciences” Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.
March 2024 in “CRC Press eBooks” Telogen effluvium is a type of hair loss where more hair than normal falls out after stress or illness.
March 2024 in “Homoeopathic links” Individualized homeopathic treatment led to complete hair regrowth in a patient with stress-induced hair loss.
March 2024 in “Indian Journal of Dermatology” Iron supplements may improve hair loss satisfaction even if initial iron levels are normal.
March 2024 in “Buletin de psihiatrie integrativă (Print)” Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.
March 2024 in “Advancements in Homeopathic Research” Homoeopathy has helped treat hair loss after Covid-19, considering the patient's overall condition.
Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.
January 2024 in “Annals of Agricultural and Environmental Medicine” Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.
January 2024 in “Medicine” Hypothyroidism is often linked to the hair loss condition telogen effluvium.
Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.
January 2024 in “Annals of dermatology/Annals of Dermatology” Weight loss can cause temporary hair loss, especially in women and older adults.
December 2023 in “Damianus Journal of Medicine” Post-COVID-19 patients are at risk for hair loss.